Status:

COMPLETED

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%

Lead Sponsor:

Galderma R&D

Conditions:

Acne Vulgaris

Eligibility:

All Genders

18-35 years

Phase:

PHASE4

Brief Summary

Phase 4 commitment pharmacokinetic study to determine systemic exposure to adapalene.

Detailed Description

Multi-center, double-blind, randomized, parallel group study enrolling male or female subjects with acne vulgaris. Screening will take place within 14 days prior to Baseline. At the Baseline visit, a...

Eligibility Criteria

Inclusion

  • Male or female 18 to 35 years of age
  • Clinical diagnosis of acne vulgaris
  • Minimum of 20 Inflammatory
  • Minimum of 20 Non-inflammatory lesions
  • The subject has a body weight between 45 and 100 kg, and a Body Mass Index (BMI) between 18 and 30Kg/m2

Exclusion

  • More than 1 nodule or any cyst on the face (excluding the nose)
  • Acne conglobata, acne fulminans, secondary acne or severe acne
  • Underlying diseases or other dermatological conditions that require the use of interfering topical or systemic therapy
  • Pregnant or nursing or planning a pregnancy
  • Surgical or medical condition which might interfere with the absorption, distribution, metabolism, or excretion of the drug
  • Known allergies to any of the ingredients of the study medication
  • History of alcohol or drug abuse or positive test results for any drug abuse
  • Positive test results for hepatitis B surface antigen (HBs-Ag), hepatitis C virus (HCV) or human immunodeficiency virus antibodies (HIV Ab)
  • Use of prohibited medications prior to the study unless appropriate washout period is documented

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT00660985

Start Date

May 1 2008

End Date

November 1 2008

Last Update

February 18 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

DermResearch, Inc.

Austin, Texas, United States, 78759

2

J&S Studies, Inc.

College Station, Texas, United States, 77845